Bullish Case: VRT has corrected -21.8% in 90 days to $253.18, yet fundamentals remain intact: Q2 revenue +24% YoY, EPS +60%, a 20-22% revenue CAGR target, and 21 of 27 analysts at Strong Buy. The Helium price-density distribution peaks near $252.5-$255, right at spot, suggesting the selloff has largely repriced near-term expectations. Calls traded 20% more volume than puts and bullish risk is 10% above bearish risk across tenors. AI data-center power/liquid-cooling demand is structural, and analyst initiations (Oct 5) plus deep-OTM call volume hint at re-rating potential into Q3 earnings (late October).

Bearish Case: Momentum is broken: VRT fell -21.8% over ninety days, recent price action is mean-reverting but weak, and the Helium AI forecast is -0.88% with a historically poor (-0.1) predictive correlation. The term structure shows Helium IV elevated above market IV through late October (71.6% vs 65.6% at Oct-31), and the surface prices expensive downside wings (10/30 245P at 67.7% IV). A demanding valuation (26x forward earnings), hyperscaler capex concentration, and one prior guidance disappointment mean another Q3 miss or backlog hesitation could drive a rapid break below $230.

Potential Outcomes:

• 40% — Drift/recovery $245-$275: Helium density peak sits at $252.5-$255 (at spot); mean-reversion + AI capex news supports a bounce. Falsifiable: sustained close above $265 by late October.
• 25% — Q3 earnings disappointment (Oct 28): Guidance or margin miss; elevated put-wing IV (10/30 245P IV 67.7%) signals tail risk. Falsifiable: close below $230 post-print.
• 15% — Beat/raise rerating +10-15%: Backlog expansion, 20-22% CAGR reaffirmed; falsifiable via Q3 release and raised guidance.
• 12% — Macro/AI capex wobble: SPY IV calm but risk-off could transmit; falsifiable via hyperscaler capex commentary.
• 8% — M&A/contract win: Falsifiable via press release.

Oracle: spot>$265 with falling front IV (Helium IV 36.6%→43.5% at 10/10-10/17) is bullish; spot<$245 with rising put IV is bearish.

October 07, 2026